A Multicentre, Open-Label Extension Phase to Study the Long-Term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia
Latest Information Update: 14 Dec 2022
At a glance
- Drugs Itopride (Primary)
- Indications Non-ulcer dyspepsia
- Focus Adverse reactions
- Sponsors Adare Pharmaceuticals
- 06 Feb 2017 Status changed from active, no longer recruiting to completed.
- 16 Jan 2017 New trial record